These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Exploration of a standard treatment for Buruli ulcer through a comprehensive analysis of all cases diagnosed in Japan. Sugawara M; Ishii N; Nakanaga K; Suzuki K; Umebayashi Y; Makigami K; Aihara M J Dermatol; 2015 Jun; 42(6):588-95. PubMed ID: 25809502 [TBL] [Abstract][Full Text] [Related]
24. Management of Mycobacterium ulcerans infection in a pregnant woman in Benin using rifampicin and clarithromycin. Dossou AD; Sopoh GE; Johnson CR; Barogui YT; Affolabi D; Anagonou SY; Zohoun T; Portaels F; Asiedu K Med J Aust; 2008 Nov; 189(9):532-3. PubMed ID: 18976206 [No Abstract] [Full Text] [Related]
25. Pharmacologic management of Van Der Werf TS; Barogui YT; Converse PJ; Phillips RO; Stienstra Y Expert Rev Clin Pharmacol; 2020 Apr; 13(4):391-401. PubMed ID: 32310683 [TBL] [Abstract][Full Text] [Related]
26. Clinical outcomes of Ghanaian Buruli ulcer patients who defaulted from antimicrobial therapy. Klis S; Kingma RA; Tuah W; van der Werf TS; Stienstra Y Trop Med Int Health; 2016 Sep; 21(9):1191-6. PubMed ID: 27456068 [TBL] [Abstract][Full Text] [Related]
27. In vitro susceptibility of Mycobacterium ulcerans to clarithromycin. Portaels F; Traore H; De Ridder K; Meyers WM Antimicrob Agents Chemother; 1998 Aug; 42(8):2070-3. PubMed ID: 9687409 [TBL] [Abstract][Full Text] [Related]
28. Buruli ulcer in West Africa: strategies for early detection and treatment in the antibiotic era. Webb BJ; Hauck FR; Houp E; Portaels F East Afr J Public Health; 2009 Aug; 6(2):144-7. PubMed ID: 20000019 [TBL] [Abstract][Full Text] [Related]
29. Susceptibilities of nontuberculosis mycobacterial species to amoxicillin-clavulanic acid alone and in combination with antimycobacterial agents. Utrup LJ; Moore TD; Actor P; Poupard JA Antimicrob Agents Chemother; 1995 Jul; 39(7):1454-7. PubMed ID: 7492084 [TBL] [Abstract][Full Text] [Related]
30. Targeting the Mycobacterium ulcerans cytochrome bc Scherr N; Bieri R; Thomas SS; Chauffour A; Kalia NP; Schneide P; Ruf MT; Lamelas A; Manimekalai MSS; Grüber G; Ishii N; Suzuki K; Tanner M; Moraski GC; Miller MJ; Witschel M; Jarlier V; Pluschke G; Pethe K Nat Commun; 2018 Dec; 9(1):5370. PubMed ID: 30560872 [TBL] [Abstract][Full Text] [Related]
31. Painful Buruli ulcer in a Malian visitor to France. Ezzedine K; Pistone T; Guir V; Malvy D Acta Derm Venereol; 2010 Jul; 90(4):424. PubMed ID: 20574617 [No Abstract] [Full Text] [Related]
32. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium]. Leclercq R; Duval J Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109 [TBL] [Abstract][Full Text] [Related]
33. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis? Pottumarthy S; Sader HS; Fritsche TR; Jones RN Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168 [TBL] [Abstract][Full Text] [Related]
34. In Vitro Activity of Selected West African Medicinal Plants against Mycobacterium ulcerans Disease. Tsouh Fokou PV; Kissi-Twum AA; Yeboah-Manu D; Appiah-Opong R; Addo P; Tchokouaha Yamthe LR; Ngoutane Mfopa A; Fekam Boyom F; Nyarko AK Molecules; 2016 Apr; 21(4):445. PubMed ID: 27089314 [TBL] [Abstract][Full Text] [Related]